SCHEMBL19804367

SCHEMBL19804367

C=C(C)C(=O)OCCc1cc(-c2ccc(-c3ccccc3CC)cc2)ccc1CCO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.36
PPARG P37231 1/20 0.36
THRB P10828 1/20 0.36
PTGER4 P35408 2/20 0.34
PTGER3 P43115 2/20 0.34
PTGER1 P34995 1/20 0.34
PTGER2 P43116 1/20 0.34
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
HSD17B1 P14061 2/20 0.33
TSHR P16473 2/20 0.33
FFAR1 O14842 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
CYP2C9 P11712 1/20 0.32
S1PR1 P21453 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804447 0.94 PPARA (0.35) PPARAPPARGTHRBPTGER4PTGER3
SCHEMBL19804036 0.92 CYP4F2 (0.38) PPARAPPARGTHRBPTGER4PTGER3
SCHEMBL19804042 0.91 RARA (0.36) THRBPTGER4PTGER3PTGER1PTGER2
SCHEMBL19804046 0.90 TDP1 (0.37) THRBPTGER4MTNR1AMTNR1BCA1
SCHEMBL19804700 0.87 FFAR1 (0.38) PPARAPPARGTHRBPTGER4PTGER3
SCHEMBL19804360 0.87 RARB (0.41) PPARAPPARGTHRBRARARARB
SCHEMBL19804446 0.85 RARA (0.37) THRBPTGER4PTGER3PTGER1PTGER2
SCHEMBL19804303 0.85 POLB (0.36) THRBPTGER4PTGER3PTGER1PTGER2
SCHEMBL19804112 0.85 CA1 (0.40) PPARAPPARGTHRBHSD17B1TSHR
SCHEMBL19796257 0.84 MCL1 (0.40) THRBTSHRCYP4F2CYP4A11RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 PPARA 3672/4885PPARG 3314/4885THRB 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.